NovoCure Limited

NovoCure Limited financial statements

NovoCure Limited's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 655.35M10-Q
Net income−USD 136.23M10-Q
Cash and equivalentsUSD 93.55M10-Q
Total debtUSD 195.05M10-Q

NovoCure Limited financials on 6ix · NovoCure Limited on 6ix